Table 15.6
Common drugs with the side-effect of dizziness

Psychotropic drugs

Antidepressants

Tricyclics, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors

Tranquillizers

Benzodiazepines, phenothiazines

Anticonvulsants

Phenytoin, carbamazepine, gabapentine, lamotrigine

Analgesics

Paracetamol, acetylsalicylate, nonsteroidal anti-inflammatory drugs, opioids

Cardiovascular drugs

Antihypertensives

Diuretics (thiazides and loop), β-blockers, calcium-channel blockers, angiotensin converting enzyme inhibitors, methyldopa, hydralazine

Anti-arrhythmic

β-blockers, verapamil, mexiletine, flecainide, miodarone, disopyramide

Anti-angina

Nitrates, calcium-channel blockers, β-blockers, potassium-channel activators

Anti-microbials

Aminoglycosides, tetracyclines, macrolides, chloroquine, isoniazid

Anti-allergic drugs

Non-sedating and sedating antihistamines

Hormone replacement/substitute

Hypoglycaemics, corticosteroids, hormone replacement therapy

Chemotherapeutic agents

Cisplatin, busulfan, cyclophosphamide, vinblastine, methotrexate

Psychotropic drugs

Antidepressants

Tricyclics, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors

Tranquillizers

Benzodiazepines, phenothiazines

Anticonvulsants

Phenytoin, carbamazepine, gabapentine, lamotrigine

Analgesics

Paracetamol, acetylsalicylate, nonsteroidal anti-inflammatory drugs, opioids

Cardiovascular drugs

Antihypertensives

Diuretics (thiazides and loop), β-blockers, calcium-channel blockers, angiotensin converting enzyme inhibitors, methyldopa, hydralazine

Anti-arrhythmic

β-blockers, verapamil, mexiletine, flecainide, miodarone, disopyramide

Anti-angina

Nitrates, calcium-channel blockers, β-blockers, potassium-channel activators

Anti-microbials

Aminoglycosides, tetracyclines, macrolides, chloroquine, isoniazid

Anti-allergic drugs

Non-sedating and sedating antihistamines

Hormone replacement/substitute

Hypoglycaemics, corticosteroids, hormone replacement therapy

Chemotherapeutic agents

Cisplatin, busulfan, cyclophosphamide, vinblastine, methotrexate

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close